Acrivon Therapeutics, Inc.
Last 30 daysNo qualifying insider buying. Sales: $585.06 by 1 insider.
Showing the first 6 of 20 trades on this page.
Chief Business Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Business Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
President and CEO; EVP - Business Operations
Common Stock
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Accounting Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Medical Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Legal Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Chief Business Officer | Common StockGrant or award | 30,000Award · no purchase price | Non-cash award | Aug 31Filed Sep 2 · 2d later | SEC filing |
| Chief Business Officer | Stock Option (Right to Buy)Grant or award | Derivative units130,000Award · no purchase price | Non-cash award | Aug 31Filed Sep 2 · 2d later | SEC filing |
| +4Director | Stock Option (Right to Buy)Grant or award | Derivative units20,275Award · no purchase price | Non-cash award | Jun 17Filed Jun 22 · 5d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units20,275Award · no purchase price | Non-cash award | Jun 17Filed Jun 22 · 5d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units20,275Award · no purchase price | Non-cash award | Jun 17Filed Jun 22 · 5d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units20,275Award · no purchase price | Non-cash award | Jun 17Filed Jun 22 · 5d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units20,275Award · no purchase price | Non-cash award | Jun 17Filed Jun 22 · 5d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units20,275Award · no purchase price | Non-cash award | Jun 17Filed Jun 22 · 5d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units20,275Award · no purchase price | Non-cash award | Jun 17Filed Jun 22 · 5d later | SEC filing |
| +1President and CEO; EVP - Business Operations | Common StockExercise-price or tax withholding | 13,729$1.79 / share | $24.57K | May 21Filed May 26 · 5d later | SEC filing |
| +4Director | Common StockGrant or award | 9,366Award · no purchase price | Non-cash award | May 18Filed May 20 · 2d later | SEC filing |
| Director | Common StockGrant or award | 9,366Award · no purchase price | Non-cash award | May 18Filed May 20 · 2d later | SEC filing |
| Director | Common StockGrant or award | 9,366Award · no purchase price | Non-cash award | May 18Filed May 20 · 2d later | SEC filing |
| Director | Common StockGrant or award | 9,366Award · no purchase price | Non-cash award | May 18Filed May 20 · 2d later | SEC filing |
| Director | Common StockGrant or award | 9,366Award · no purchase price | Non-cash award | May 18Filed May 20 · 2d later | SEC filing |
| Director | Common StockGrant or award | 9,366Award · no purchase price | Non-cash award | May 18Filed May 20 · 2d later | SEC filing |
| Director | Common StockGrant or award | 9,366Award · no purchase price | Non-cash award | May 18Filed May 20 · 2d later | SEC filing |
| Chief Accounting Officer | Common StockGrant or award | 14,227Award · no purchase price | Non-cash award | May 18Filed May 20 · 2d later | SEC filing |
| Chief Medical Officer | Common StockGrant or award | 38,817Award · no purchase price | Non-cash award | May 18Filed May 20 · 2d later | SEC filing |
| Chief Legal Officer | Common StockGrant or award | 49,830Award · no purchase price | Non-cash award | May 18Filed May 20 · 2d later | SEC filing |
Showing the latest 20 of 33 trades. Show all 33 trades
This reflects the filings imported so far, not a complete trading history.
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
